Markedly divergent effects of Ouabain on a Temozolomide-resistant (T98G) vs. a Temozolomide-sensitive (LN229) Glioblastoma cell line

• Published in: Discover. Oncology Vol. 14; no. 1; p. 27
• Main Authors: Weidemann, Heidrun, Feger, Daniel, Ehlert, Jan E., Menger, Marcus M., Krempien, Robert C.
• Format: Journal Article
• Language: English
• Published: New York Springer US 25-02-2023; Springer Nature B.V; Springer
• Subjects: Angiogenesis; Antibiotics; Apoptosis; Bcl-2; Brain cancer; Cancer Research; Cancer therapies; Cell adhesion & migration; Cell cycle; Cell growth; Cell migration; Chemoresistance; Drug dosages; Drug resistance; Glioblastoma; Hormones; Internal Medicine; Kinases; Lymphoma; Medicine; Medicine & Public Health; Molecular Medicine; Na/K-ATPase; Oncology; Ouabain; Plasma; Radiation therapy; Radiotherapy; Steroids; Surgical Oncology; Germany; Bcl-2; Plasma cell membrane potential; Pan-Akt; Chemoresistance; Glioblastoma; Na/K-ATPase; Ouabain; Cell migration
• ISSN: 2730-6011; 2730-6011
• DOI: 10.1007/s12672-023-00633-2

Background
Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor with poor prognosis. GMB are highly recurrent mainly because of radio- and chemoresistance. Radiotherapy with Temozolomide (TMZ) is until today the golden standard adjuvant therapy, however, the optimal treatment of recurrent glioblastoma remains controversial. Ouabain belongs to the Cardiotonic Steroids (CTS) the natural ligands of the Na/K-ATPase (NKA). It is established that the NKA represents a signal transducer with either stimulating or inhibiting cell growth, apoptosis, migration and angiogenesis. Over the last decade evidence grew that CTS have anti-tumor properties especially in GBM.
Aim
Proceeding from recent studies we wanted to further demonstrate a divergent effect of Ouabain on a TMZ-resistant (T98G) as compared to a TMZ-sensitive (LN229) GBM cell line.
Methods
We analyzed the effect of Ouabain on cell migration and plasma cell membrane potential (PCMP) in the LN229 and T98G GBM cell line as well as underlying mechanisms (Bcl-2 and p-Akt/pan-Akt expression). Moreover, we analyzed the anti-angiogenic effect of Ouabain on human umbilical vein endothelial cells (HUVECs).
Results
T98G cells showed a significant inhibition of cell migration and a significant depolarization of the PCMP at similar Ouabain concentrations (IC50 = 1.67 × 10
–7
 M) resp. (IC50 = 2.72 × 10
–7
 M) with a strong inverse correlation (R
2
 = 0.95). In contrast, LN229 cells did not respond to Ouabain in these assays at all. Similarly, only T98G but not LN229 cells revealed Bcl-2 down-regulation at nanomolar Ouabain concentrations. This unique response to Ouabain is associated with a down-regulation of pan-Akt in T98G cells 24 h after Ouabain (1.0 × 10
–6
 M) treatment. For the first time, the anti-angiogenic effect of Ouabain on HUVEC cells (IC50 = 5.49 × 10
–8
 M) was demonstrated which correlated strongly with the anti-migratory effect (R
2
 = 0.85).
Conclusion
The TMZ-resistant T98G cell line as compared to the TMZ-sensitive LN229 cell line shows a high sensitivity towards Ouabain. We consider it as a promising new compound especially in recurrent GBM to overcome the resistance to TMZ and irradiation.